Canlyniadau chwilio am the

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

Click here to learn what the duty of candour looks like in practice.

What our standards say on scope of practice

Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.

The Fitness to practise annual report highlights key statistics and insights and explains how we protect the public and ensure our registrants meet our standards

Both the Partner Expenses Policy and claim form are now available for you to access from the policies section of the Partner Hub.

We required that all education providers embedded our revised standards of proficiency (SOPs) from September 2023. We have assessed education provider alignment with the SOPs, and have considered common practices and challenges with this alignment.

This webinar will explore the benefits regular reflection can have on your practice and share examples of some of the ways you can achieve reflective practice.

We are seeking views from all our stakeholders on this draft vision, and the other key components which make up our draft corporate strategy

Key findings from our year in registration survey, which aims to gather insight about how students’ education and training prepares them for practice. 

Learn how to overcome the challenges of being open and honest in practice.